Biotech, U.S.A., USD 500 Million

  • Home
  • /
  • Biotech, U.S.A., USD 500 Million

Client

The client has deep roots in chemistry and engineering. They create and manufacture engineered primary packaging container components for the Pharmaceutical and Biotechnology industry.

Scenario

The client needs money for business expansion and new projects.

Solution

Wealthbullet arranged a credit line of USD 500 million in the form of a 5-year convertible loan note, with a debenture on the company.

USD

500 Million

Country

U.S.A.

Sector

Pharmaceuticals

Sub-sector

Biotech

Deal Type

Acquisition

Structure

Convertible Loan Note

Loved this? Spread the word



Related posts

Read More
Read More
Read More
Read More

Contact us

Contact us by clicking the button below

>